Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-08-03 4:59 pm Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 81,187 1.000% | -655,295 (-88.98%) | View |
2023-07-17 07:30 am Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 736,482 8.700% | -92,639 (-11.17%) | View |
2023-04-10 4:40 pm Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 829,121 9.500% | -178,795 (-17.74%) | View |
2023-01-30 4:30 pm Purchase | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 1,007,916 11.350% | 1,007,916 (New Position) | View |
2022-10-05 4:35 pm Unchanged | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,134,610 19.900% | 0 (Unchanged) | View |
2022-06-30 5:58 pm Unchanged | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,134,610 19.900% | 0 (Unchanged) | View |
2022-06-24 4:54 pm Unchanged | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,134,610 19.900% | 0 (Unchanged) | View |
2021-06-07 5:25 pm Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,134,610 19.900% | -1,600 (-0.01%) | View |
2021-03-31 9:02 pm Sale | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 17,136,210 19.900% | -1,717,218 (-9.11%) | View |
2020-12-30 09:16 am Purchase | 13D | Aceragen Inc. ACGN | Pillar Pharmaceuticals 6 L.P. | 18,853,428 19.900% | 18,853,428 (New Position) | View |